Giken Holdings Co.,Ltd.
1443・Standard Market・Construction
Business
Giken Holdings is a construction-focused holding company centered on its wholly owned subsidiary Giken Kogyo Co., Ltd., operating three business segments: civil engineering, building construction, and formwork leasing. The civil engineering-related business focuses on slope protection and steep slope countermeasure work, the building construction-related business centers on radiation shielding and electromagnetic wave shielding work for medical facilities, and the formwork leasing-related business involves leasing steel formwork for manufacturing wave-dissipating foundation blocks and selling secondary concrete products. Major customers include public institutions and medical facilities, with the company specializing in highly public-interest areas such as social infrastructure development, disaster prevention, and medical environment development. Originating from Giken Kogyo, founded in 1958, the company transitioned to a holding company structure in 2018. It is listed on the Standard Market of the Tokyo Stock Exchange.
Business Model
The building construction-related business (FY2026 (ending March 2026) net sales of ¥2,420 million, operating margin of 17.7%) and the formwork rental-related business (net sales of ¥1,346 million, operating margin of 27.9%), which together account for more than half of total revenue, form the pillars of high profitability. Formwork rental generates stock-type earnings by repeatedly leasing out already-invested steel formwork, and has room for margin improvement as depreciation expenses decline over time. In civil engineering and construction work, the company thoroughly applies a profitability-focused order selection strategy, raising margins by eliminating unprofitable projects.
Company Strengths
In FY2026 (ending March 2026), the company achieved an operating margin of 15.0% (up 2.3 points year on year) and a gross margin of 27.7% (up 1.3 points year on year). Despite a 4.7% year-on-year decline in net sales, operating profit increased 12.5% to ¥701 million, demonstrating that the shift from "quantity to quality"—achieved through the elimination of unprofitable construction projects and thorough fixed-cost reductions—is functioning effectively in practice.
The construction-related business has handled specialized construction work such as radiation shielding since 1962, accumulating over 60 years of construction track record. Radiation shielding and electromagnetic shielding construction for medical facilities is a field requiring advanced technical capabilities and a proven track record, and the company has built ongoing client relationships that also capture equipment renewal demand from previously constructed facilities. The order backlog carried forward into FY2026 (ending March 2026) stood at ¥1,892 million, providing support for sales in the following fiscal year.
The formwork rental-related business achieved an operating margin of 27.9% in FY2026 (ending March 2026), the highest profitability level within the group. Steel formwork is a stock-type business in which manufactured units are repeatedly leased out, and there remains room for further margin improvement, as evidenced by depreciation expenses of ¥49 million in the current period, a substantial decrease from the previous year. Supported by stable demand for public works projects, order volume remained roughly flat, up 0.3% year on year.
ENVALITH's Perspective
Performance Trend
Consolidated net sales for FY2026 (ending March 2026) totaled ¥4,675 million (down 4.7% year on year), marking a fifth consecutive year of declining revenue. However, operating profit rose to ¥701 million (up 12.5% year on year), ordinary profit to ¥892 million (up 15.9%), and profit attributable to owners of parent to ¥613 million (up 24.7%), achieving profit growth for a third consecutive year. Gross profit was roughly flat year on year at ¥1,296 million, and the main driver of the increase in operating profit was a ¥80 million reduction in SG&A expenses, from ¥674 million to ¥594 million. Externally, elevated prices and shortages of construction materials have persisted over the long term, but the company has absorbed the cost increases through selective order-taking that prioritizes profitability and thorough cost management. Operating cash flow improved substantially to ¥928 million from ¥358 million in the prior period, and the interest coverage ratio recovered sharply from 6.6x to 19.9x. For FY2027 (ending March 2027), the company forecasts net sales of ¥4,900 million, operating profit of ¥750 million, and net income of ¥640 million.
Growth Strategy
Strengthening the earnings base through profitability-focused order selection, thorough cost management, and development of high-value-added products
The company continues its strategy of improving profit margins even as revenue declines. Operating margin in the construction-related business improved from 13.8% to 17.7%, and the company-wide operating margin rose from 12.7% to 15.0%. Reductions in SG&A expenses (from ¥674 million to ¥594 million) have also contributed, and the company targets operating profit of ¥750 million (margin of 15.3%) for FY2027 (ending March 2027).
Orders received in the civil engineering-related business, mainly slope protection construction, surged 60.3% year on year to ¥1,455 million, and the order backlog carried forward to the next period reached ¥1,056 million (up ¥621 million from the end of the previous period). Backed by public budget execution related to national resilience (kokudo kyojinka) initiatives, the capacity for revenue recognition in the following period has expanded significantly.
The company is promoting the development of high-value-added products utilizing the specialized technologies of each business in order to enhance market competitiveness. Through an integrated end-to-end system in cooperation with group companies, it aims to strengthen price competitiveness and build a stable revenue base and a robust management foundation. In the construction-related business, the company is also working to expand the proportion of orders from fields other than medical.
The company continued repaying long-term borrowings (financing cash outflow of ¥465 million), while improving the equity ratio from 67.5% to 70.7%. While maintaining a robust financial base including investment securities of ¥8,473 million, the debt redemption period was significantly shortened from 9.2 years to 3.1 years. This improvement in financial soundness supports creditworthiness and competitiveness in securing orders.
Last updated: July 19, 2026